Cost-Effectiveness Analysis of Brentuximab Vedotin With Chemotherapy in Newly Diagnosed Stage III and IV Hodgkin Lymphoma.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2018